Author profile

Shahin Ghaseminejad

University of Western Ontario

Presenting AuthorPoster

A More Precise Way of Calculating the Dose Distribution at a Sub-Cellular Level In Radioligand Therapy

To accurately calculate the cellular-level absorbed dose for 225Ac, 177Lu, and 161Tb radioligand therapy (RLT), accounting for tumor microstructure, self-irradiation, crossfire, and bystander effects.

Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Presenting AuthorPoster

Optimizing Radiopharmaceutical Dosage: A DNA Damage-Based Framework to Maximize Tumor Control and Minimize Normal Tissue Damage

We introduce a framework to optimize administered radioligand activity by calculating DNA lethal lesions (LLs), balancing maximal tumor control with minimal normal tissue damage.

Poster Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine